Oncolytics Biotech Inc T.ONC

Amgen to acquire Horizon Therapeutics for US$26.4 Billion

[Noteable]

"The California-based biotech leader will pay $116.50 for each share of Horizon, according to Reuters. Struck just three weeks before the close of 2022, it is biopharma’s largest deal of the year."

"Rumors of a potential acquisition first started circulating last month, after WSJbroke the story. At the time, the company confirmed it was fielding offers from three industry giants - Amgen, Sanofi and Janssen - though discussions were still “highly preliminary.”

https://www.biospace.com/article/amgen-to-buy-horizon-in-biotech-s-biggest-deal-of-2022-/

[Noteable]

Founded in 2005 Horizon Therapeutics traded at $2.00/share in 2013.

[TMAZZ21]

I noticed that too, but your talking over eight years ago trading at $2 Also Noteable how many shares do you have?  I figure since you post so much daily every hour or two you must be holding north of 100K shares?

[Buckhenry]

no one on here has any clue that anyone is interested or even looking at us. unless you have hard facts shut the forever pumping up. 

[Noteable]

Horizon Therapeutics has been primarily a "Generics Drug" company until recently when it developed a proprietary drug line in specialty products focusing on immunology. ONCY is a proprietary drug company with a focus on immuno- oncology. (immunology/oncology).

[Noteable]

"The deal is expected to close in the first half of 2023, Amgen executives said on a conference call Monday morning."   Meanwhile, Sanofi on Sunday said it was “no longer in discussions with Horizon and it does not intend to make an offer for Horizon.” The French drugmaker explained that the “transaction price expectations do not meet our value creation

[fox7mf]

We know, or can comfortably assume that we are in discussions with at least 2 industry giants, maybe at least 3 ( Merck, Roche & PFE.) I would also assume we're further along in said discussions than 'preliminary.' We could use a WSJ or Bloomberg report/leak to get things moving. We could also use that $26.4b. GL.

[Noteable]

Horizon's $28B sale to Amgen was kicked off by Sanofi's interest "Amgen plans to buy Horizon Therapeutics for about $28 billion in cash, bringing on board two "immunology" drugs to ease the hit the biotech giant faces from biosimilar competition." [ Amgen's patent cliff has prompted the company to engage in the kind of acquistion that I had posted about earlier

[Buckhenry]

all folks have been doing on here for quite some time is assuming. again no factual data ... just lots of forever pumpers here ... we all know what happens when we assume. 

[itntdf]

yes, and "amam" was $0.41 around the close last thursday and shot up to over $4.50 on friday for over a 1,000% increase. this is the fomo about which many are fearful with oncy.